Article
Rapid, point-of-care molecular diagnostics with Cas13
2020-12-16
Abstract excerpt
<h4>Summary</h4> Rapid nucleic acid testing is a critical component of a robust infrastructure for increased disease surveillance. Here, we report a microfluidic platform for point-of-care, CRISPR-based molecular diagnostics. We first developed a nucleic acid test which pairs distinct mechanisms of DNA and RNA amplification optimized for high sensitivity and rapid kinetics, linked to Cas13 detection for specificit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 840769d1-0577-5ee2-a299-e0269bcf34cf
- DOI
- 10.1101/2020.12.14.20247874
